Lilly 3234 Pill — RED;GRAY CAPSULE, 18mm — Fluoxetine
| Imprint | Lilly / 3234 |
|---|---|
| Colour | RED;GRAY |
| Shape | CAPSULE |
| Size | 18 |
| Strength | Olanzapine 12 mg;Fluoxetine hydrochloride 50 mg |
| Dosage form | Capsule |
| Manufacturer | Eli Lilly and Company |
| NDC | 0002-3234 |
| Schedule | — |
| Availability | — |
| Ingredients | Olanzapine[Olanzapine];Fluoxetine hydrochloride[Fluoxetine] |
What does this imprint mean?
The imprint "Lilly 3234" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Fluoxetine
Uses and warnings
BOXED WARNING: BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glaucoma in susceptible patients - Hyponatremia/SIADH - QT interval prolongation - Cognitive and motor impairment potential --- | BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glauc
Fluoxetine is indicated for: - "Acute and maintenance treatment of Major Depressive Disorder" - "Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD)" - "Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa" - "Acute treatment of Panic Disorder, with or without agoraphobia" ---
How to identify this pill
- • Check the imprint matches exactly: "Lilly 3234".
- • Confirm the colour (RED;GRAY) and shape (CAPSULE).
- • Compare the size (18) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Other pills of Fluoxetine
SG 115
BLUE;WHITE CAPSULE · Fluoxetine
250 par
YELLOW CAPSULE · Fluoxetine
253 par
GRAY;RED CAPSULE · Fluoxetine
566 20
WHITE OVAL · Fluoxetine
E 92
GREEN;ORANGE CAPSULE · Fluoxetine
E 91
GREEN;WHITE CAPSULE · Fluoxetine
Lilly 3230
PINK;YELLOW CAPSULE · Fluoxetine
TEVA 5504
ORANGE CAPSULE · Fluoxetine
SG 114
BLUE;GREEN CAPSULE · Fluoxetine
TEVA 7198
BLUE;ORANGE CAPSULE · Fluoxetine
RX632
GREEN CAPSULE · Fluoxetine
PLIVA 648
WHITE CAPSULE · Fluoxetine
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 26cacdee-6ad3-4f22-b10c-d85d589be3b6.xml